In a surprising discovery, a "sticky molecule" that occurs naturally in our blood vessels could be both a culprit behind ...
Professor Greg Neely, Head of the Dr. John and Anne Chong Lab for Functional Genomics at the University of Sydney.rnrn"In some cases people can't ...
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...
An MIT spin-off company called Sherlock Biosciences has gotten FDA approval to begin using its CRISPR-based COVID-19 test, which promises to be faster and easy to perform without access to a full lab.
Researchers are racing to develop quick, home-based tests for the virus that could deliver test results in minutes. None do that yet, but several... CRISPR And Spit Might Be Keys To Faster, Cheaper, ...
By Clay Alspach The U.S. government is turning its back on a medical breakthrough that has saved millions of lives, halting $500 million in federal funding to develop new mRNA […] ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced that Dr. Martin ...
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.